Chloe Williams is a science journalist and editor based in Yellowknife, Northwest Territories, and a former intern at The Transmitter. She writes about the environment and health. Her work has appeared in The New York Times, Hakai Magazine and Yale Environment 360, among other publications. She completed a master’s degree in the Science, Health and Environmental Reporting Program at New York University.
Chloe Williams
Contributing writer
The Transmitter
From this contributor
Molecular changes after MECP2 loss may drive Rett syndrome traits
Knocking out the gene in adult mice triggered up- and down-regulated expression of myriad genes weeks before there were changes in neuronal function.
Molecular changes after MECP2 loss may drive Rett syndrome traits
By
Chloe Williams
20 March 2025 | 5 min read
Brain patterning in utero may be implicated in autism, other conditions
Genes tied to several conditions are expressed in regions that control neural stem cell fate within the first few months post-conception.
Brain patterning in utero may be implicated in autism, other conditions
By
Chloe Williams
1 August 2024 | 6 min read
‘Retro-Cascorder’ tracks gene-expression timing
The new tool may help researchers reconstruct the sequence of biological events that underlie development.
‘Retro-Cascorder’ tracks gene-expression timing
By
Chloe Williams
19 August 2022 | 6 min listen
Scans of sundry variant types uncover autism-linked genes
Troves of sequencing data reveal genes tied to autism through different variant types, providing a more complete picture of the condition’s genetic roots and new clues to its heterogeneity.
Scans of sundry variant types uncover autism-linked genes
By
Chloe Williams
18 August 2022 | 7 min read
Plethora of protein-making machines in neurons may underlie fragile X
An overabundance of ribosomes drives an imbalance of proteins produced from long and short genetic transcripts in a mouse model of fragile X syndrome.
Plethora of protein-making machines in neurons may underlie fragile X
By
Chloe Williams
21 July 2022 | 6 min read
Explore more from The Transmitter
Single-cell genomics technologies and cell atlases have ushered in a new era of human neurobiology
Single-cell approaches are already shedding light on the human brain, identifying cell types that are most vulnerable in the early stages of Alzheimer’s disease, for example.
Single-cell genomics technologies and cell atlases have ushered in a new era of human neurobiology
Single-cell approaches are already shedding light on the human brain, identifying cell types that are most vulnerable in the early stages of Alzheimer’s disease, for example.
By
Ed Lein, Hongkui Zeng
24 March 2025 | 7 min read
Bespoke photometry system captures variety of dopamine signals in mice
The tool tracks the excitation of an engineered protein that senses dopamine’s absolute levels, including fast and slow fluctuations in real time, and offers new insights into how the signals change across the brain.
Bespoke photometry system captures variety of dopamine signals in mice
The tool tracks the excitation of an engineered protein that senses dopamine’s absolute levels, including fast and slow fluctuations in real time, and offers new insights into how the signals change across the brain.
By
Sydney Wyatt
21 March 2025 | 5 min read
What infant fMRI is revealing about the developing mind
Cognitive neuroscientists have finally clocked how to perform task-based functional MRI experiments in awake babies—long known for their inability to lie still or take direction. Next, they aim to watch cognition take shape and settle a debate about our earliest memories—with one group publishing a big clue today.
What infant fMRI is revealing about the developing mind
Cognitive neuroscientists have finally clocked how to perform task-based functional MRI experiments in awake babies—long known for their inability to lie still or take direction. Next, they aim to watch cognition take shape and settle a debate about our earliest memories—with one group publishing a big clue today.
By
Calli McMurray
20 March 2025 | 12 min read